Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Lasa Supergenerics Ltd - 540702 - Closure of Trading Window

 This is to inform you that as per the Company''s code of conduct for Regulating, Monitoring and Reporting of Trading by insiders in term of (Prohibition of Insider Trading) Regulations, 2015 as amended, the Trading window for dealing in the equity shares of the company has been closed for designated employees and their immediate relatives wef July 01, 2024 till 48 hours after conclusion of unaudited Financial results (both days inclusive) for the Quarter ended June 30,2024
29-06-2024
Bigul

Lasa Supergenerics Ltd - 540702 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

 We wish to inform you that the Member of the company has approved by the way postal Ballot the following resolutions under companies act 2013 read with SEBI Listing Regulation as set out in the Notices of postal Ballot Dated May 22 2024 with Requisite Majority Item No 1 Appointment of Mr. Umesh Pawar Din 10539778 as the Whole Time Director Designated as Executive Director for the term of 5 year commencing from March 08, 2024 As per Scrutinizer Report dated Wednesday June 26 2024 the aforesaid resolution has been passed with requisite majority on Wednesday June 26 2024
26-06-2024
Bigul

Lasa Supergenerics Ltd - 540702 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot

 We wish inform you that the member of the compnay has approved the the way of postal ballot the following resolution under companies act 2013 read with SEBI listing regulation res out in the notice of postal ballot Dated May 22 2024 with Requisite Majority item No 1 Appointment of Umesh Pawar Din 10539778 as the whole time Director designated as Executive Director for the term of 5 years from 08th March 2024 As per Scrutinizer report dated Wednesday June 26 2024 the aforesaid resolution has been passed with requisite Majority on Wednesday June 26 2024
26-06-2024
Bigul

The menace of LASA drugs

 The very existence of countless misleading brand names shows that India's drug regulator, Central Drugs Standard Control Organisation (CDSCO), is not doing what it is tasked to do, a recent study in Lancet Regional Healthnoted.
21-06-2024
Bigul

Lasa Supergenerics Ltd - 540702 - Disclosure Of Related Party Transaction Under Regulation 23(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015

 Pursuant to Regulation 23(9) of SEBI (Listing Obligation and Disclosure Requirement) Regulation 2015 Please find enclosed herewith disclosure of Related Party Transaction for the year ended March 31 2024
30-05-2024
Bigul

Lasa Supergenerics Ltd - 540702 - Board Meeting Outcome for Board Meeting

 Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 8.00 p.m. and concluded at 10.45 p.m. inter- alia have considered and approved the following: The statement of Audited Financial Results of the Company for the quarter and the financial year ended on March 31, 2024 A copy of the statement of audited Financial Results, Cash Flow statement along with Audited Report submitted by the Statutory Auditors of the Company is attached herewith
30-05-2024
Bigul

Lasa Supergenerics Ltd - 540702 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Pursuant to SEBI circular CIR/CFD/CMD1/27/2019 Dated 8th February , 2019 ,please find enclosed copy of Annual Secretarial Compliance Report dated 27th May, 2024 issued by Shivam Sharma & Associates for the FY - 2023-24
29-05-2024
Bigul

Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for For The Quarter And Year Ended March 31St, 2024

 Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Thursday, May 30, 2024, inter alia; 1. To consider, approve and take on records Audited financial results of the Company for the quarter and the year ended March 31, 2024. 2. To discuss any other matter with the permission of the Chairperson.
24-05-2024
Bigul

Lasa Supergenerics Ltd - 540702 - Notice Of Postal Ballot, Seeking Shareholders' Approval For Appointment Of Mr. Umesh Pawar As Executive Director

 Pursuant to Regulation 30 of Securities Exchange Board Of India (Listing Obligation and Disclosure Requirement) Regulation, 2015, we enclosed herewith postal Ballot Notice, Seeking Approval of Member of the Company
22-05-2024
Bigul

Lasa Supergenerics Ltd - 540702 - Declaration With Respect To Non -Applicability Of Large Entities Framework Pursuant To SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 Dated 26Th November, 2018

 Pursuant to circular No SEBI/HO/DDHS/CIP/P/2018/144 dated 26th November, 2018 for fund raising by issuances of debt Securities by large entities and Compliance thereof we hereby submit that our company is out of the purview of Large Corporate category as per the applicability of framework provided in the aforesaid Circular
30-04-2024
Next Page
Close

Let's Open Free Demat Account